Treatment outcomes of patients with stage III non–small cell lung cancer and interstitial lung diseases receiving intensity‐modulated radiation therapy: A single‐center experience of 85 cases

OBJECTIVES: Whether curative‐intent radiotherapy could be safely applied to lung cancer patients with interstitial lung diseases (ILD) remains unclear. We aim to evaluate radiation induced lung toxicities (RILTs) and the efficacy of intensity‐modulated radiotherapy (IMRT) in these patients. ILD is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Linfang, Zhao, Shijun, Huang, Hui, Wang, Wenqing, Zhang, Tao, Zhou, Zongmei, Feng, Qinfu, Liang, Jun, Xiao, Zefen, Hui, Zhouguang, Lv, Jima, Bi, Nan, Wang, Luhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161336/
https://www.ncbi.nlm.nih.gov/pubmed/35451221
http://dx.doi.org/10.1111/1759-7714.14418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161336/
https://www.ncbi.nlm.nih.gov/pubmed/35451221
http://dx.doi.org/10.1111/1759-7714.14418

Ejemplares similares